Trials / Terminated
TerminatedNCT05139147
DAISe 1 Feasibility Study to Evaluate the DAISe Thrombectomy System for Acute Ischemic Stroke
A Prospective, Multi-Center, Single Arm, Feasibility Study to Evaluate the DAISe Thrombectomy System During Neurointervention for Acute Ischemic Stroke; DAISe 1 Study
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- MIVI Neuroscience, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is a prospective, multi-center, single arm, feasibility study that will enroll a maximum of 36 subjects. The maximum enrollment is 10 subjects per site. A maximum of 6 investigational centers in Europe will participate. Enrollment is expected to take about 9 months, subject participation will last about 3 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | DAISe Thrombectomy System | DAISe Thrombectomy System for mechanical thrombectomy |
Timeline
- Start date
- 2022-01-12
- Primary completion
- 2023-07-20
- Completion
- 2023-08-04
- First posted
- 2021-12-01
- Last updated
- 2024-08-09
Locations
6 sites across 1 country: France
Source: ClinicalTrials.gov record NCT05139147. Inclusion in this directory is not an endorsement.